Treatment with all- trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia : A multicenter study by the PETHEMA groupORTEGA, Juan J; MADERO, Luis; RODRIGUEZ, Antonia et al.Journal of clinical oncology. 2005, Vol 23, Num 30, pp 7632-7640, issn 0732-183X, 9 p.Article

Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyCERVERA, José; MONTESINOS, Pau; MILONE, Gustavo et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 424-431, issn 0390-6078, 8 p.Article

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcomeSANZ, Miguel A; MONTESINOS, Pau; RIVAS, Concha et al.Blood. 2010, Vol 115, Num 25, pp 5137-5146, issn 0006-4971, 10 p.Article

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy : long-term outcome of the LPA 99 multicenter study by the PETHEMA GroupSANZ, Miguel A; MONTESINOS, Pau; RIVAS, Concha et al.Blood. 2008, Vol 112, Num 8, pp 3130-3134, issn 0006-4971, 5 p.Article

Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant studyREDONDO, Alba M; POMARES, Helena; ALONSO, Natalia et al.British journal of haematology. 2014, Vol 164, Num 5, pp 668-674, issn 0007-1048, 7 p.Article

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimensMONTESINOS, Pau; RAYON, Chelo; RIVAS, Concha et al.Blood. 2011, Vol 117, Num 6, pp 1799-1805, issn 0006-4971, 7 p.Article

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based ChemotherapyMONTESINOS, Pau; GONZALEZ, José D; DEBEN, Guillermo et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3872-3879, issn 0732-183X, 8 p.Article

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicinDE LA SERNA, Javier; MONTESINOS, Pau; RIVAS, Concha et al.Blood. 2008, Vol 111, Num 7, pp 3395-3402, issn 0006-4971, 8 p.Article

Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxisMONTESINOS, Pau; DIAZ-MEDIAVILLA, Joaquin; GONZALEZ, José et al.Haematologica (Roma). 2009, Vol 94, Num 9, pp 1242-1249, issn 0390-6078, 8 p.Article

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy : characteristics, outcome, and prognostic factorsMONTESINOS, Pau; BERGUA, Juan M; RIVAS, Concha et al.Blood. 2009, Vol 113, Num 4, pp 775-783, issn 0006-4971, 9 p.Article